Signals, Powered By EquityPandit
Zydus Cadila has got the USFDA approval for marketing tizanidine hydrochloride capsules which is a muscle relaxant, in the American market.
Zydus Cadila has said in a regulatory filing that “The company has received final approval from the US Food and Drug Administration (USFDA) to market tizanidine hydrochloride capsules, USP in strengths of 2mg, 4mg and 6mg.”
The durg is going to get produced at the group’s manufacturing SEZ facility in Ahmedabad.
